Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B
Thirty-two patients with chronic hepatitis B treated with alpha interferon were tested for 12 different antibodies. Only a minority (18%) of cases developed antinuclear antibodies and none developed clinical signs of autoimmune disease. These data suggest that, at the dose regimen used, interferon therapy of chronic hepatitis B is not associated with triggering of autoimmunity.
KeywordsChronic Hepatitis Alpha Interferon Interferon Therapy Hepatitis Delta Virus Alpha Interferon Treatment
Unable to display preview. Download preview PDF.
- 1.Burman P, Karlsson FA, Oberg K, Alm G (1985) Autoimmune thyroid disease in interferon-treated patients. Lancet ii: 100–101Google Scholar
- 2.Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Buschenfelde KH (1989) Treatment of chronic type B hepatitis with recombinant-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10: 24–28Google Scholar
- 3.Perillo RP (1989) Interferon therapy for chronic typeB hepatitis: The promise comes of age. Gastroenterology 96: 532–536Google Scholar